- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Over the Counter (OTC) Drugs & Dietary Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Over the Counter (OTC) Drugs & Dietary Supplements market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Over the Counter (OTC) Drugs & Dietary Supplements global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Analgesic & Pain Relievers segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Over the Counter (OTC) Drugs & Dietary Supplements include Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., and Sanofi S.A, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Over the Counter (OTC) Drugs & Dietary Supplements market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Market segment by players, this report covers
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Over the Counter (OTC) Drugs & Dietary Supplements product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Over the Counter (OTC) Drugs & Dietary Supplements, with revenue, gross margin and global market share of Over the Counter (OTC) Drugs & Dietary Supplements from 2019 to 2022.
Chapter 3, the Over the Counter (OTC) Drugs & Dietary Supplements competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Over the Counter (OTC) Drugs & Dietary Supplements market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Over the Counter (OTC) Drugs & Dietary Supplements research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Over the Counter (OTC) Drugs & Dietary Supplements
1.2 Classification of Over the Counter (OTC) Drugs & Dietary Supplements by Type
1.2.1 Overview: Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type in 2021
1.2.3 Analgesic & Pain Relievers
1.2.4 Dermatological Products
1.2.5 Cough, Cold, and Flu Products
1.2.6 Vitamin Supplements
1.2.7 Mineral Supplements
1.2.8 Ophthalmic Products
1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market by Application
1.3.1 Overview: Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size & Forecast
1.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast by Region
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region, (2017-2022)
1.5.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Prospect (2017-2028)
1.5.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Prospect (2017-2028)
1.5.6 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
1.6.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
1.6.3 Over the Counter (OTC) Drugs & Dietary Supplements Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Pfizer Inc. Recent Developments and Future Plans
2.2 Novartis International AG
2.2.1 Novartis International AG Details
2.2.2 Novartis International AG Major Business
2.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis International AG Recent Developments and Future Plans
2.3 Roche Holding AG
2.3.1 Roche Holding AG Details
2.3.2 Roche Holding AG Major Business
2.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Roche Holding AG Recent Developments and Future Plans
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck & Co., Inc. Recent Developments and Future Plans
2.5 Sanofi S.A
2.5.1 Sanofi S.A Details
2.5.2 Sanofi S.A Major Business
2.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Sanofi S.A Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business
2.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Gilead Sciences Recent Developments and Future Plans
2.8 GlaxoSmithKline plc.
2.8.1 GlaxoSmithKline plc. Details
2.8.2 GlaxoSmithKline plc. Major Business
2.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 GlaxoSmithKline plc. Recent Developments and Future Plans
2.9 Bayer Healthcare AG
2.9.1 Bayer Healthcare AG Details
2.9.2 Bayer Healthcare AG Major Business
2.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Bayer Healthcare AG Recent Developments and Future Plans
2.10 AstraZeneca plc.
2.10.1 AstraZeneca plc. Details
2.10.2 AstraZeneca plc. Major Business
2.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 AstraZeneca plc. Recent Developments and Future Plans
2.11 Alacer Corp.
2.11.1 Alacer Corp. Details
2.11.2 Alacer Corp. Major Business
2.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.11.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Alacer Corp. Recent Developments and Future Plans
2.12 Alcon Inc.
2.12.1 Alcon Inc. Details
2.12.2 Alcon Inc. Major Business
2.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.12.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Alcon Inc. Recent Developments and Future Plans
2.13 Alfresa Pharma Corporation
2.13.1 Alfresa Pharma Corporation Details
2.13.2 Alfresa Pharma Corporation Major Business
2.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.13.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Alfresa Pharma Corporation Recent Developments and Future Plans
2.14 Alkalon A/S
2.14.1 Alkalon A/S Details
2.14.2 Alkalon A/S Major Business
2.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.14.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Alkalon A/S Recent Developments and Future Plans
2.15 Alliance Healthcare
2.15.1 Alliance Healthcare Details
2.15.2 Alliance Healthcare Major Business
2.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Alliance Healthcare Recent Developments and Future Plans
2.16 Allergan, Plc.
2.16.1 Allergan, Plc. Details
2.16.2 Allergan, Plc. Major Business
2.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Allergan, Plc. Recent Developments and Future Plans
2.17 Reckitt Benckiser Plc.
2.17.1 Reckitt Benckiser Plc. Details
2.17.2 Reckitt Benckiser Plc. Major Business
2.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.17.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Reckitt Benckiser Plc. Recent Developments and Future Plans
2.18 Bausch & Lomb
2.18.1 Bausch & Lomb Details
2.18.2 Bausch & Lomb Major Business
2.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.18.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Bausch & Lomb Recent Developments and Future Plans
2.19 AbbVie Inc.
2.19.1 AbbVie Inc. Details
2.19.2 AbbVie Inc. Major Business
2.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.19.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 AbbVie Inc. Recent Developments and Future Plans
2.20 The Colgate-Palmolive Company
2.20.1 The Colgate-Palmolive Company Details
2.20.2 The Colgate-Palmolive Company Major Business
2.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
2.20.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 The Colgate-Palmolive Company Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share in 2021
3.2.2 Top 10 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Over the Counter (OTC) Drugs & Dietary Supplements Players Head Office, Products and Services Provided
3.4 Over the Counter (OTC) Drugs & Dietary Supplements Mergers & Acquisitions
3.5 Over the Counter (OTC) Drugs & Dietary Supplements New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Market Share by Type (2017-2022)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2017-2022)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2028)
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2028)
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2028)
6.3.2 United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
6.3.3 Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
6.3.4 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2028)
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2028)
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
7.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2028)
7.3.2 Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
7.3.3 France Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
7.3.5 Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
7.3.6 Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2028)
8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2028)
8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
8.3.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2017-2028)
8.3.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
8.3.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
8.3.4 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
8.3.5 India Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
8.3.7 Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2028)
9.2 South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2028)
9.3 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
9.3.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2028)
9.3.2 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
9.3.3 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2028)
10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2028)
10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
10.3.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2028)
10.3.2 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
10.3.4 UAE Over the Counter (OTC) Drugs & Dietary Supplements Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) by Region (2017-2022)
Table 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2023-2028)
Table 6. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Inc. Major Business
Table 8. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 9. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis International AG Corporate Information, Head Office, and Major Competitors
Table 11. Novartis International AG Major Business
Table 12. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 13. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 15. Roche Holding AG Major Business
Table 16. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 17. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Merck & Co., Inc. Major Business
Table 20. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 21. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Sanofi S.A Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi S.A Major Business
Table 24. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 25. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson & Johnson Major Business
Table 28. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 29. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 31. Gilead Sciences Major Business
Table 32. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 33. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. GlaxoSmithKline plc. Corporate Information, Head Office, and Major Competitors
Table 35. GlaxoSmithKline plc. Major Business
Table 36. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 37. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Bayer Healthcare AG Corporate Information, Head Office, and Major Competitors
Table 39. Bayer Healthcare AG Major Business
Table 40. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 41. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. AstraZeneca plc. Corporate Information, Head Office, and Major Competitors
Table 43. AstraZeneca plc. Major Business
Table 44. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 45. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Alacer Corp. Corporate Information, Head Office, and Major Competitors
Table 47. Alacer Corp. Major Business
Table 48. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 49. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Alcon Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Alcon Inc. Major Business
Table 52. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 53. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Alfresa Pharma Corporation Corporate Information, Head Office, and Major Competitors
Table 55. Alfresa Pharma Corporation Major Business
Table 56. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 57. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Alkalon A/S Corporate Information, Head Office, and Major Competitors
Table 59. Alkalon A/S Major Business
Table 60. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 61. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Alliance Healthcare Corporate Information, Head Office, and Major Competitors
Table 63. Alliance Healthcare Major Business
Table 64. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 65. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Allergan, Plc. Corporate Information, Head Office, and Major Competitors
Table 67. Allergan, Plc. Major Business
Table 68. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 69. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Reckitt Benckiser Plc. Corporate Information, Head Office, and Major Competitors
Table 71. Reckitt Benckiser Plc. Major Business
Table 72. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 73. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Bausch & Lomb Corporate Information, Head Office, and Major Competitors
Table 75. Bausch & Lomb Major Business
Table 76. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 77. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 79. AbbVie Inc. Major Business
Table 80. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 81. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. The Colgate-Palmolive Company Corporate Information, Head Office, and Major Competitors
Table 83. The Colgate-Palmolive Company Major Business
Table 84. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product and Solutions
Table 85. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 87. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 88. Breakdown of Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Over the Counter (OTC) Drugs & Dietary Supplements Players Head Office, Products and Services Provided
Table 90. Over the Counter (OTC) Drugs & Dietary Supplements Mergers & Acquisitions in the Past Five Years
Table 91. Over the Counter (OTC) Drugs & Dietary Supplements New Entrants and Expansion Plans
Table 92. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) by Type (2017-2022)
Table 93. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2017-2022)
Table 94. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2023-2028)
Table 95. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2022)
Table 96. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2023-2028)
Table 97. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2022) & (USD Million)
Table 98. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2023-2028) & (USD Million)
Table 99. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2022) & (USD Million)
Table 100. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2023-2028) & (USD Million)
Table 101. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2022) & (USD Million)
Table 102. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2023-2028) & (USD Million)
Table 103. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2022) & (USD Million)
Table 104. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2023-2028) & (USD Million)
Table 105. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2022) & (USD Million)
Table 106. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2023-2028) & (USD Million)
Table 107. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2022) & (USD Million)
Table 108. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2023-2028) & (USD Million)
Table 109. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2022) & (USD Million)
Table 110. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2023-2028) & (USD Million)
Table 111. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2022) & (USD Million)
Table 112. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2023-2028) & (USD Million)
Table 113. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2017-2022) & (USD Million)
Table 114. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2023-2028) & (USD Million)
Table 115. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2022) & (USD Million)
Table 116. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2023-2028) & (USD Million)
Table 117. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2022) & (USD Million)
Table 118. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2023-2028) & (USD Million)
Table 119. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2022) & (USD Million)
Table 120. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2023-2028) & (USD Million)
Table 121. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2017-2022) & (USD Million)
Table 122. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2023-2028) & (USD Million)
Table 123. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2017-2022) & (USD Million)
Table 124. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2023-2028) & (USD Million)
Table 125. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2017-2022) & (USD Million)
Table 126. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Picture
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type in 2021
Figure 3. Analgesic & Pain Relievers
Figure 4. Dermatological Products
Figure 5. Cough, Cold, and Flu Products
Figure 6. Vitamin Supplements
Figure 7. Mineral Supplements
Figure 8. Ophthalmic Products
Figure 9. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application in 2021
Figure 10. Hospital Pharmacies Picture
Figure 11. Retail Pharmacies Picture
Figure 12. Online Pharmacy Picture
Figure 13. Others Picture
Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2017-2028)
Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region in 2021
Figure 18. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
Figure 24. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
Figure 25. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
Figure 26. Pfizer Inc. Recent Developments and Future Plans
Figure 27. Novartis International AG Recent Developments and Future Plans
Figure 28. Roche Holding AG Recent Developments and Future Plans
Figure 29. Merck & Co., Inc. Recent Developments and Future Plans
Figure 30. Sanofi S.A Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. Gilead Sciences Recent Developments and Future Plans
Figure 33. GlaxoSmithKline plc. Recent Developments and Future Plans
Figure 34. Bayer Healthcare AG Recent Developments and Future Plans
Figure 35. AstraZeneca plc. Recent Developments and Future Plans
Figure 36. Alacer Corp. Recent Developments and Future Plans
Figure 37. Alcon Inc. Recent Developments and Future Plans
Figure 38. Alfresa Pharma Corporation Recent Developments and Future Plans
Figure 39. Alkalon A/S Recent Developments and Future Plans
Figure 40. Alliance Healthcare Recent Developments and Future Plans
Figure 41. Allergan, Plc. Recent Developments and Future Plans
Figure 42. Reckitt Benckiser Plc. Recent Developments and Future Plans
Figure 43. Bausch & Lomb Recent Developments and Future Plans
Figure 44. AbbVie Inc. Recent Developments and Future Plans
Figure 45. The Colgate-Palmolive Company Recent Developments and Future Plans
Figure 46. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players in 2021
Figure 47. Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 48. Global Top 3 Players Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in 2021
Figure 49. Global Top 10 Players Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in 2021
Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 51. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type in 2021
Figure 52. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Type (2023-2028)
Figure 53. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application in 2021
Figure 54. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share Forecast by Application (2023-2028)
Figure 55. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2017-2028)
Figure 56. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2017-2028)
Figure 57. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2017-2028)
Figure 58. United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Canada Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2017-2028)
Figure 62. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2017-2028)
Figure 63. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2017-2028)
Figure 64. Germany Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. France Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. United Kingdom Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Russia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Italy Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2017-2028)
Figure 70. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2017-2028)
Figure 71. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2017-2028)
Figure 72. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Australia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2017-2028)
Figure 79. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2017-2028)
Figure 80. South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2017-2028)
Figure 81. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2017-2028)
Figure 86. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. UAE Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Methodology
Figure 90. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
